Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas ...
The latest CorEvitas registry – the company’s 11th independent registry – will allow the prospective evaluation of adolescent AD patients to better understand the disease and the treatment pathway. It ...
Thermo Fisher Scientific TMO announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) Registry, designed to study novel treatments for the most common inflammatory ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) Registry, designed to study novel ...
Higher disease activity is linked to faster eGFR decline and a greater risk for significant kidney dysfunction in RA.
Iran has a number of sensitive sites, including oil infrastructure, military installations and nuclear facilities. By Lazaro Gamio and Eve Sampson With the region on edge about a possible ...